RoundUp® Lawsuit

For decades, the makers of RoundUp® weed killer marketed the product to American homeowners as a quick, easy, and safe solution for controlling broadleaf weeds. Its use has also extended far beyond residential lawns and gardens to include large-scale agricultural operations and row crops nationwide. However, recent studies have linked this widely used product to serious health problems, including non-Hodgkin’s lymphoma.

If RoundUp exposure caused you or a loved one to develop non-Hodgkin’s lymphoma, you may join the ongoing RoundUp lawsuit to pursue compensation.

What is glyphosate?

Since 1974, the Environmental Protection Agency (EPA) has registered glyphosate for use in the United States. Farmers and gardeners frequently use it to control broadleaf weeds and grasses.

Glyphosate effectively controls a broad range of invasive and harmful weeds. Manufacturers sell products containing glyphosate in various formulations, including liquid concentrates, ready-to-use sprays, and solid forms. They commonly include glyphosate in products such as RoundUp for weed control in residential, commercial, and agricultural settings.

What is non-Hodgkin’s lymphoma

Non-Hodgki n lymphoma (or simply lymphoma) is a type of cancer that begins in white blood cells called lymphocytes, which are part of the body’s immune system. It includes a broad group of blood cancers, most commonly B-cell lymphomas and T-cell lymphomas.

In non-Hodgkin’s lymphoma, certain genes inside B cells or T cells mutate. These abnormal cells often collect in the lymph nodes, forming tumors. They can also develop in other lymphatic organs or in lymph tissue found throughout the body.

The most common early sign of non-Hodgkin’s lymphoma is painless swelling in the neck, armpits, or groin, caused by enlarged lymph nodes. Other symptoms vary depending on where the lymphoma is growing, but may include fatigue, night sweats, unexplained fever, and more.

Does RoundUp increase the risk of non-Hodgkin’s lymphoma?

For years, manufacturers and marketers led consumers to believe that RoundUp was not harmful to humans. However, newer research has linked its active ingredient, glyphosate, to an increased risk of non-Hodgkin’s lymphoma.

A major 2019 study reported that individuals with the highest exposure to glyphosate-based herbicides had a 41% higher risk of developing non-Hodgkin’s lymphoma compared to those with lower exposure levels.

These concerns gained additional weight in December 2025, when the journal Regulatory Toxicology and Pharmacology (RTP), a leading publication focused on how toxicology and pharmacology data guide government safety regulations, retracted a widely cited paper published in 2000 that had concluded glyphosate was safe. The retraction followed revelations that the study authors failed to disclose payments from Monsanto, RoundUp’s manufacturer, and that company employees allegedly ghostwrote portions of the review.

What is the RoundUp lawsuit?

Research has linked glyphosate, the active ingredient in RoundUp, to non-Hodgkin’s lymphoma. Lawsuits allege that Monsanto, which Bayer Group acquired in 2018, knew about the cancer risks associated with glyphosate and deliberately concealed this information from consumers.

In March 2015, the International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans.” This determination was based on evidence of cancer observed in humans through real-world exposure, as well as findings from studies on animals.

Following IARC’s classification, RoundUp cancer litigation gained momentum. Beginning in 2016, farmers, agricultural workers, landscapers, and other individuals filed claims against Monsanto, alleging the company failed to adequately warn the public about potential health risks associated with RoundUp.

Since these lawsuits began, people have filed thousands of claims against Bayer and Monsanto.

RoundUp settlements

In recent years, thousands of claimants have received their due compensation through RoundUp settlements after alleging the herbicide caused them to develop cancer.

Some notable settlements in RoundUp litigation include:

2020: Bayer, which acquired RoundUp’s manufacturer, announced plans to pay nearly $11 billion to resolve existing RoundUp cancer claims.
2023: Bayer agreed to pay $6.9 million to the New York Attorney General to settle allegations that the company misled consumers about the safety of its products.
January 2024: A Pennsylvania jury awarded $2.25 billion, the largest single RoundUp verdict to date, to a man who developed cancer after using RoundUp on his property for more than 20 years.
March 2025: A Georgia jury awarded nearly $2.1 billion to a man who developed non-Hodgkin’s lymphoma following several years of RoundUp use.
As of 2025, RoundUp settlements have totaled approximately $11 billion, resolving about 100,000 lawsuits.

However, individual settlement amounts are far smaller than these billion-dollar figures, typically averaging between $5,000 and $250,000, though compensation can vary from case to case.

Joining the RoundUp lawsuit

If RoundUp exposure led you or a loved one to develop non-Hodgkin’s lymphoma, you may be eligible to join the RoundUp lawsuit.

"*" indicates required fields

Phone

This field is for validation purposes and should be left unchanged.

Your Name*

Your Email Address

Your Best Phone Number*